Recent

% | $
Quotes you view appear here for quick access.

Keryx Biopharmaceuticals Inc. Message Board

  • mandoesit mandoesit May 8, 2013 2:38 PM Flag

    Zerenex Beats Rivals in Efficay, Safety & Administration Advantages.

    Seeking Alpha Keryx: A Small Biotech With Many Catalysts
    May 8 2013 By: George RHO
    Considering Zerenex's efficacy, safety, and administration advantages, versus the three main rivals in the market, as well as its unique ability to provide iron benefits, Keryx's ferric citrate has the potential to becomethe leading phosphate binder in the world. We believe the shares still have considerable upside potential, to be realized in the quarters and years ahead.

 
KERX
10.755-0.145(-1.33%)2:15 PMEDT